Home - POCTRN
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
Our goal is to develop technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.
Our Centers
Atlanta Center for Microsystems Engineered Point-of-Care Technologies
Focus: To develop and translate microsystems-engineered technologies including microchip-enabled devices that include microelectromechanical systems (MEMs)-based sensors, microfluidics, and smartphone-based systems.
Llegeix mésAl voltant deAtlanta Center for Microsystems Engineered Point-of-Care Technologies »
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
Focus: To develop and test the accuracy, acceptability, and optimal implementation of point-of-care tests for sexually transmitted diseases in diverse care delivery contexts both in the United States and in resource-limited settings.
Llegeix mésAl voltant deCenter for Point-of-Care Technologies Research for Sexually Transmitted Diseases »
Center for Innovation in Point of Care Technologies for HIV/AIDS at Northwestern
Focus: To support the development of a pipeline of Point-of-Care Technologies designed to meet the clinical needs of people who live with HIV/AIDS in low- and middle-income countries.
Llegeix mésAl voltant deCenter for Innovation in Point of Care Technologies for HIV/AIDS at Northwestern »
Center for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases
Focus: To support development and testing of promising “late-stage” point of care technologies that can be rapidly deployed to enhance the diagnosis, monitoring, management and/or treatment of heart, lung, blood and sleep disorders.
Llegeix mésAl voltant deCenter for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases »
Editor de continguts
binx health Receives FDA CLIA Waiver for Chlamydia and Gonorrhea Test, Expanding Critical Access to Single-Visit Diagnoses
First ever 30-minute, CLIA-waived, molecular PCR Test for CT/NG now available for OBGYN, physician offices and retail settings holding certificates of waiver
Llegeix mésAl voltant debinx health Receives FDA CLIA Waiver for Chlamydia and Gonorrhea Test, Expanding Critical Access to Single-Visit Diagnoses »
NIH-funded COVID-19 home test is first to receive over-the-counter authorization from FDA
Ellume USA’s rapid at-home test was developed through the NIH RADx Initiative.
Llegeix mésAl voltant deNIH-funded COVID-19 home test is first to receive over-the-counter authorization from FDA »
WhenToTest.org
The COVD19 Testing Impact Calculator
Llegeix mésAl voltant deWhenToTest.org »
In the News
-
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
-
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
- The National Strategy From the COVID-19 Response and Pandemic Preparedness
- Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced
- The Need for More and Better Testing for COVID-19